Latest MF59 Stories

2008-10-16 12:00:25

Research and Markets (http://www.researchandmarkets.com/research/e1ceb5/stakeholder_opinio) has announced the addition of the "Stakeholder Opinions: Vaccine Adjuvants - Uncertainties Rule" report to their offering. Adjuvants are coming increasingly into focus for vaccine developers since many novel split- and subunit vaccines are insufficiently immunogenic on their own. Adjuvants offer a solution: they can accelerate, enhance and prolong the immune response to vaccination but also enable...

2008-08-08 12:00:45

Novartis has started shipments of its Fluvirin influenza virus vaccine to US health care facilities and practitioners for the 2008/2009 influenza season. The company is producing up to 40 million doses of Fluvirin, with the World Health Organization recommended change in all three virus strains included in the influenza vaccine composition. Novartis expects to deliver at least 20 million doses by the end of September 2008, when widespread vaccination campaigns usually begin, and strives...

Word of the Day
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.